Ironwood Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.67-$5.78 |
Market Cap | $632.1M |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $361.5M |
Revenue Growth (YoY) | 158.9% |
Gross Profit (12 Mos) | $271.8M |
Diluted EPS | $0.62 |
News
See moreYahoo Finance • 11 days ago
These small-cap healthcare stocks pair revenue growth with attractive valuations
Yahoo Finance • 19 days ago
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
Yahoo Finance • 26 days ago
Is Ironwood Pharmaceuticals, Inc. (IRWD) Strengthening Its Growth Outlook With Expanded Pediatric Approval for Linzess?
Yahoo Finance • 3 months ago
Ironwood (IRWD) is One of the Most Attractive Small-Cap Drug Manufacturers, Here is Why
About
CEO | Mr. Thomas A. McCourt |
CFO | Mr. Ronald Silver |
Address | 100 Summer Street, Boston, MA, United States, 02110 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 100 |